View Future GrowthUBE 과거 순이익 실적과거 기준 점검 2/6UBE의 수입은 연평균 -16.1%의 비율로 감소해 온 반면, Chemicals 산업은 수입이 연평균 5.4% 증가했습니다. 매출은 연평균 7.9%의 비율로 감소해 왔습니다. UBE의 자기자본이익률은 5.3%이고 순이익률은 5.2%입니다.핵심 정보-16.14%순이익 성장률-15.33%주당순이익(EPS) 성장률Chemicals 산업 성장률6.58%매출 성장률-7.93%자기자본이익률5.30%순이익률5.16%다음 순이익 업데이트07 Aug 2026최근 과거 실적 업데이트공시 • Mar 26+ 3 more updatesUBE Corporation to Report Q1, 2027 Results on Aug 07, 2026UBE Corporation announced that they will report Q1, 2027 results on Aug 07, 2026Reported Earnings • Aug 06First quarter 2026 earnings released: EPS: JP¥44.90 (vs JP¥49.49 in 1Q 2025)First quarter 2026 results: EPS: JP¥44.90 (down from JP¥49.49 in 1Q 2025). Revenue: JP¥100.5b (down 13% from 1Q 2025). Net income: JP¥4.36b (down 9.2% from 1Q 2025). Profit margin: 4.3% (in line with 1Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Reported Earnings • Jun 25Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: JP¥49.60 loss per share (down from JP¥299 profit in FY 2024). Revenue: JP¥486.8b (up 4.0% from FY 2024). Net loss: JP¥4.82b (down 117% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 68%. Revenue is forecast to stay flat during the next 3 years compared to a 3.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.Reported Earnings • May 13Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: JP¥49.60 loss per share (down from JP¥299 profit in FY 2024). Revenue: JP¥486.8b (up 4.0% from FY 2024). Net loss: JP¥4.82b (down 117% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 68%. Revenue is forecast to stay flat during the next 3 years compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.공시 • Mar 28+ 2 more updatesUBE Corporation to Report Q3, 2026 Results on Feb 04, 2026UBE Corporation announced that they will report Q3, 2026 results on Feb 04, 2026공시 • Mar 01UBE Corporation to Report Fiscal Year 2025 Results on May 12, 2025UBE Corporation announced that they will report fiscal year 2025 results on May 12, 2025모든 업데이트 보기Recent updates공시 • May 13UBE Corporation, Annual General Meeting, Jun 25, 2026UBE Corporation, Annual General Meeting, Jun 25, 2026.공시 • Mar 26+ 3 more updatesUBE Corporation to Report Q1, 2027 Results on Aug 07, 2026UBE Corporation announced that they will report Q1, 2027 results on Aug 07, 2026공시 • Jan 16UBE Corporation Announces Restructuring of Domestic Production System in Cement-Related BusinessUBE Cement Corporation announced that, at the Board of Directors meeting, MUCC resolved to cease cement production at Kyushu Plant Kanda District 2 by around the end of March 2027 and to transform the district into a recycling promotion base specializing in various types of waste treatment, as described below. The business environment for the cement industry continues to face pressures from declining domestic demand and reduced profitability in export markets. Against this backdrop, MUCC is advancing initiatives to strengthen profitability and improve asset efficiency, aiming to achieve sustainable growth and enhance corporate value over the medium to long term. Meanwhile, as MUCC seeks to achieve carbon neutrality by 2050, a key effort is to improve its thermal energy substitution rate. In particular, MUCC considers it essential to expand the volume of waste treatment for thermal recycling at the Kyushu Plant, which has one of the leading cement production capacities in Japan, and to achieve a thermal energy substitution rate of 50% or more for MUCC as a whole. Under these circumstances, in order to establish an optimal operation system and strengthen the competitiveness of its cement business, MUCC will cease cement production at Kyushu Plant Kanda District 2 by around the end of March 2027 and consolidate operations at Kyushu Plant Kanda District 1, thereby improving the efficiency of production facilities across the entire Kyushu Plant. In addition, to maximize the use of its technologies and further improve the waste treatment substitution rate, MUCC will develop Kyushu Plant Kanda District 2 as a recycling promotion base, utilizing existing facilities for crushing and packing waste plastics and removing chlorine and foreign materials. MUCC will steadily execute these measures to further enhance corporate value and help build a sustainable society.분석 기사 • Dec 04UBE's (TSE:4208) Dividend Will Be ¥55.00UBE Corporation ( TSE:4208 ) has announced that it will pay a dividend of ¥55.00 per share on the 29th of June. Based...Declared Dividend • Dec 03First half dividend of JP¥55.00 announcedDividend of JP¥55.00 is the same as last year. Ex-date: 30th March 2026 Payment date: 29th June 2026 Dividend yield will be 4.5%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is not covered by earnings (186% earnings payout ratio) nor is it covered by cash flows (114% cash payout ratio). The dividend has increased by an average of 8.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 106% to bring the payout ratio under control. EPS is expected to grow by 63% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.분석 기사 • Sep 05UBE (TSE:4208) Is Reinvesting At Lower Rates Of ReturnDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...Reported Earnings • Aug 06First quarter 2026 earnings released: EPS: JP¥44.90 (vs JP¥49.49 in 1Q 2025)First quarter 2026 results: EPS: JP¥44.90 (down from JP¥49.49 in 1Q 2025). Revenue: JP¥100.5b (down 13% from 1Q 2025). Net income: JP¥4.36b (down 9.2% from 1Q 2025). Profit margin: 4.3% (in line with 1Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.분석 기사 • Jul 24UBE (TSE:4208) Is Due To Pay A Dividend Of ¥55.00The board of UBE Corporation ( TSE:4208 ) has announced that it will pay a dividend of ¥55.00 per share on the 3rd of...분석 기사 • Jul 10UBE (TSE:4208) Has Announced A Dividend Of ¥55.00UBE Corporation's ( TSE:4208 ) investors are due to receive a payment of ¥55.00 per share on 3rd of December. This...Declared Dividend • Jul 09Final dividend of JP¥55.00 announcedDividend of JP¥55.00 is the same as last year. Ex-date: 29th September 2025 Payment date: 3rd December 2025 Dividend yield will be 4.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.2% per year over the past 10 years. However, payments have been volatile during that time.Reported Earnings • Jun 25Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: JP¥49.60 loss per share (down from JP¥299 profit in FY 2024). Revenue: JP¥486.8b (up 4.0% from FY 2024). Net loss: JP¥4.82b (down 117% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 68%. Revenue is forecast to stay flat during the next 3 years compared to a 3.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.New Risk • Jun 24New major risk - Revenue and earnings growthEarnings have declined by 21% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (11% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 21% per year over the past 5 years.Reported Earnings • May 13Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: JP¥49.60 loss per share (down from JP¥299 profit in FY 2024). Revenue: JP¥486.8b (up 4.0% from FY 2024). Net loss: JP¥4.82b (down 117% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 68%. Revenue is forecast to stay flat during the next 3 years compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.공시 • May 12+ 2 more updatesUBE Corporation, Annual General Meeting, Jun 26, 2025UBE Corporation, Annual General Meeting, Jun 26, 2025.분석 기사 • May 08Here's Why UBE (TSE:4208) Has A Meaningful Debt BurdenDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...Board Change • Apr 28High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Outside Director Tatsuya Tanaka was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.공시 • Apr 02UBE Corporation (TSE:4208) completed the acquisition of Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for approximately €500 million.UBE Corporation (TSE:4208) signed a contract to acquire Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for an enterprise value of €460 million on October 3, 2024. For the last twelve months period ending September 30, 2024, Urethane Systems Business of LANXESS reported total revenue of €265 million and EBITDA of €50 million. The acquisition price is expected to be confirmed based on the price adjustment indicated in the stock purchase agreement. The acquisition will be financed through cash on hand and interest-bearing debt. The Urethane Systems business comprises 5 manufacturing sites globally as well as application laboratories in the USA, Europe and China. UBE Corporation will take over all operations from LANXESS with a total of around 400 employees. LANXESS will use the proceeds to reduce its net debt. The transaction is subject to the approval of the relevant authorities including regulatory approval. The transaction is expected to close in the first half of 2025. Nomura Holding America, Inc. acted as financial advisor to UBE Corporation. Matthias Töke, Katharina Spenner LL.M., Joachim Fröhlich LL.M., Katharina Weiner, Daniel Bork, Christoph Becker, Ariane Schaaf, Simone (Bach) Rieken LL.M., Johannes M. Baumann, LL.M., Christian Atzler, Christian Vocke, Richard Raoul Stefanink, Patrick H. Wilkening, Markus Hecht, Christian Reichel and Nicolas Kredel LL.M. of Baker & Mckenzie Partnerschaft Von Rechtsanwälten Wirtschaftsprüfern,Steuerberatern Und Solicitors acted as legal advisor to UBE Corporation. Masahiro Inaba, Byron Frost and Tetsuo Tsujimoto of Baker & McKenzie (Gaikokuho Joint Enterprise) acted as legal advisor to UBE Corporation. UBE Corporation (TSE:4208) completed the acquisition of Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for approximately €500 million on April 1, 2025. All relevant antitrust authorities had granted the necessary approvals for the transaction공시 • Mar 28+ 2 more updatesUBE Corporation to Report Q3, 2026 Results on Feb 04, 2026UBE Corporation announced that they will report Q3, 2026 results on Feb 04, 2026공시 • Mar 01UBE Corporation to Report Fiscal Year 2025 Results on May 12, 2025UBE Corporation announced that they will report fiscal year 2025 results on May 12, 2025공시 • Feb 19+ 1 more updateUbe Corporation Announces CEO Changes, Effective from April 1, 2025UBE Corporation announced that its Board of Directors resolved on February 19, 2025, to make the following changes to directors. Masato Izumihara, Current Position: President and Representative Director CEO, New Position: Chairman of the Board of Directors. Yuki Nishida, Current Position: Representative Director Senior Managing Executive Officer, New Position: President and Representative Director CEO. Yuki Nishida: Date of Birth: January 16, 1962. Birthplace: Hiroshima Prefecture. Career Highlights: March 1987 Master's Degree of Applied Chemistry, Faculty of Engineering, Hiroshima University; April 1987 Joined Ube Industries Ltd. (currently UBE Corporation); June 1987 Fine Chemicals Manufacturing Department, Ube Chemical Factory; November 1990 Development Department, Chemicals Division; March 1996 Business Development Department, Fine & Industrial Chemicals Business Unit, Chemicals & Plastics Division; February 2000 Transferred to UBE Europe (Dusseldorf, Germany); April 2003 Transferred to UBE Chemicals Europe (Madrid, Spain); January 2005 Sales Group Leader, Fine Chemicals Business Unit, Specialty Chemicals & Products Division; December 2006; General Manager, Fine Chemicals Business Unit, Specialty Chemicals & Products Division; April 2015; General Manager, Battery Materials and Fine Chemicals Business Unit, Chemicals Company; April 2016: Executive Officer General Manager, Battery Materials and Fine Chemicals Business Unit, Chemicals Company; April 2017: Executive Officer General Manager, Battery Materials and Fine Chemicals Division, Chemicals Company; April 2019: Managing Executive Officer General Manager, Engineering Plastics & Fine Chemicals Division, Chemicals Company; April 2021: Managing Executive Officer General Manager, Engineering Plastics & Fine Chemicals Division; April 2022: Senior Managing Executive Officer Assistant to the President, General Manager, Production & Technology Division, and DX Promotion Office, with responsibility for Information Systems Department; July 2022: Senior Managing Executive Officer Assistant to the President, General Manager, Production & Technology Division, and DX Promotion Office, with responsibility for Information Systems Department and C1 Chemicals Project; April 2024: Senior Managing Executive Officer Assistant to the President, General Manager, DX Promotion Office, with responsibility for Information Systems Department and C1 Chemicals Project; June 2024: Representative Director and Senior Managing Executive Officer Assistant to the President, General Manager, DX Promotion Office, with responsibility for Information Systems Department and C1 Chemicals Project (current position); April 2025: President and Representative Director CEO, with responsibility for DX Promotion Office, Information Systems Department, and C1 Chemicals Project (pending approval).공시 • Jan 28+ 1 more updateUBE Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025UBE Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2025. For the year, the company expects net sales to be JPY 490.0 billion against previous guidance of JPY 510.0 billion. Operating profit to be JPY 16.0 billion against previous guidance of JPY 27.0 billion. Loss attributable to owners of parent to be JPY 17.5 billion against previous guidance of profit attributable to owners of parent of JPY 29.5 billion. Net loss per share to be JPY 180.24 against previous guidance of net income per share to be JPY 303.89. Reasons for the Revision: Net sales are expected to fall below the previous forecast mainly due to the transfer of management rights of UBE Steel Co. Ltd. in Machinery Segment, in November 2024. Operating profit is also projected to come in lower than the previous forecast as sales of caprolactam and nylon polymer in the Polymers & Chemicals Segment have been sluggish due to the impact of oversupply by Chinese companies. Ordinary profit is projected to be lower than the previous forecast due to a decrease in operating profit as mentioned above. Additionally, in the first half (interim period), the company dissolved an equity-method affiliate engaged in the elastomer business in Malaysia, recording share of loss of entities accounted for using the equity method. Profit attributable to owners of parent is expected to be lower than the previous forecast. Ordinary profit is expected to decline as described earlier. Additionally, as a result of the decision to implement structural reform in the basic businesses, the company plans to record approximately JPY 35 billion in impairment losses and other related expenses. For details on the structural reform of the basic businesses, please refer to UBE Announces Structural Reform of Basic Businesses to Achieve Vision for 2030 released on January 28, 2025.Declared Dividend • Dec 04First half dividend of JP¥55.00 announcedShareholders will receive a dividend of JP¥55.00. Ex-date: 28th March 2025 Payment date: 27th June 2025 Dividend yield will be 4.6%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (53% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 45% over the next 3 years, which should provide support to the dividend and adequate earnings cover.New Risk • Nov 09New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 15% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Minor Risk Paying a dividend despite having no free cash flows.Reported Earnings • Nov 09Second quarter 2025 earnings released: JP¥46.20 loss per share (vs JP¥55.26 profit in 2Q 2024)Second quarter 2025 results: JP¥46.20 loss per share (down from JP¥55.26 profit in 2Q 2024). Revenue: JP¥127.7b (up 17% from 2Q 2024). Net loss: JP¥4.49b (down 184% from profit in 2Q 2024). Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.분석 기사 • Nov 08Getting In Cheap On UBE Corporation (TSE:4208) Might Be DifficultThere wouldn't be many who think UBE Corporation's ( TSE:4208 ) price-to-sales (or "P/S") ratio of 0.5x is worth a...공시 • Oct 31UBE Corporation Revises Earnings Forecast for the First Half of Fiscal Year Ending March 31, 2025UBE Corporation revised earnings forecast for the First Half of fiscal year ending March 31, 2025. For the period,the company expected net sales of JPY 243,000 Million operating profit of JPY 6,000 Million and profit attributable to owners of parent of JPY 300 million or JPY 3.09 per basic share as compared to previous guidance of net sales of JPY 238,000 Million operating profit of JPY 7,500 Million and profit attributable to owners of parent of JPY 8,000 million or JPY 82.41 per basic share. Reasons for the Revision: Net sales are expected to exceed the previous forecast due to an increase in the selling price of elastomers as a result of rising raw material prices, despite sluggish sales of certain products in the Specialty Products Segment. Operating profit is projected to be lower than the previous forecast due to the impact of the lower of cost or market method on caprolactam, nylon polymers, and other products, in the Polymers & Chemicals Segment. Ordinary profit and profit attributable to owners of parent are expected to be significantly lower than previously forecast due to the posting of a share of loss of entities accounted for using equity method following the dissolution of LOTTE UBE SYNTHETIC RUBBER SDN. BHD., an equity method affiliate.분석 기사 • Oct 17Investors Could Be Concerned With UBE's (TSE:4208) Returns On CapitalWhen researching a stock for investment, what can tell us that the company is in decline? A business that's potentially...공시 • Oct 04+ 1 more updateiSigma Capital Corporation agreed to acquire 84.25% stake in Ube Steel Co.,Ltd from UBE Corporation (TSE:4208).iSigma Capital Corporation agreed to acquire 84.25% stake in Ube Steel Co.,Ltd from UBE Corporation (TSE:4208) on October 3, 2024.Upcoming Dividend • Sep 20Upcoming dividend of JP¥55.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 4.1%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.4%).Reported Earnings • Aug 06First quarter 2025 earnings released: EPS: JP¥49.49 (vs JP¥37.67 in 1Q 2024)First quarter 2025 results: EPS: JP¥49.49 (up from JP¥37.67 in 1Q 2024). Revenue: JP¥115.4b (up 5.6% from 1Q 2024). Net income: JP¥4.80b (up 31% from 1Q 2024). Profit margin: 4.2% (up from 3.3% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to JP¥2,185, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥1,711 per share.Declared Dividend • Jul 11Final dividend of JP¥55.00 announcedShareholders will receive a dividend of JP¥55.00. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 3.9%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (35% earnings payout ratio) and cash flows (49% cash payout ratio). The dividend has increased by an average of 8.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 28% over the next 3 years, which should provide support to the dividend and adequate earnings cover.Reported Earnings • Jun 26Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2024 results: EPS: JP¥299 (up from JP¥72.25 loss in FY 2023). Revenue: JP¥468.2b (down 5.4% from FY 2023). Net income: JP¥29.0b (up JP¥36.0b from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) exceeded analyst estimates by 31%. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.Price Target Changed • Jun 15Price target increased by 9.8% to JP¥3,092Up from JP¥2,817, the current price target is an average from 6 analysts. New target price is 13% above last closing price of JP¥2,735. Stock is up 11% over the past year. The company is forecast to post earnings per share of JP¥301 for next year compared to JP¥299 last year.Major Estimate Revision • Jun 15Consensus EPS estimates increase by 14%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from JP¥499.9b to JP¥515.7b. EPS estimate increased from JP¥265 to JP¥301 per share. Net income forecast to grow 0.8% next year vs 10% growth forecast for Chemicals industry in Japan. Consensus price target up from JP¥2,817 to JP¥3,092. Share price was steady at JP¥2,735 over the past week.Reported Earnings • May 16Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2024 results: EPS: JP¥299 (up from JP¥72.25 loss in FY 2023). Revenue: JP¥468.2b (down 5.4% from FY 2023). Net income: JP¥29.0b (up JP¥36.0b from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) exceeded analyst estimates by 31%. Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.공시 • May 15+ 2 more updatesUBE Corporation to Report First Half, 2025 Results on Nov 07, 2024UBE Corporation announced that they will report first half, 2025 results on Nov 07, 2024Buy Or Sell Opportunity • May 14Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 20% to JP¥3,014. The fair value is estimated to be JP¥2,489, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 11% over the last 3 years. Earnings per share has declined by 54%. For the next 3 years, revenue is forecast to grow by 5.0% per annum. Earnings are also forecast to grow by 19% per annum over the same time period.분석 기사 • May 01Is UBE (TSE:4208) A Risky Investment?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...공시 • Apr 26+ 1 more updateUBE Corporation, Annual General Meeting, Jun 26, 2024UBE Corporation, Annual General Meeting, Jun 26, 2024. Agenda: To approve the Change of Representative Director and Executive Personnel.분석 기사 • Apr 13Estimating The Fair Value Of UBE Corporation (TSE:4208)Key Insights UBE's estimated fair value is JP¥2,482 based on 2 Stage Free Cash Flow to Equity With JP¥2,830 share...Price Target Changed • Mar 27Price target increased by 8.3% to JP¥2,817Up from JP¥2,600, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥2,750. Stock is up 33% over the past year. The company is forecast to post earnings per share of JP¥230 next year compared to a net loss per share of JP¥72.25 last year.Upcoming Dividend • Mar 21Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 3.6%. Within top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).분석 기사 • Mar 19Market Participants Recognise UBE Corporation's (TSE:4208) EarningsWith a price-to-earnings (or "P/E") ratio of 18.2x UBE Corporation ( TSE:4208 ) may be sending bearish signals at the...공시 • Mar 02UBE Corporation to Report Fiscal Year 2024 Results on May 13, 2024UBE Corporation announced that they will report fiscal year 2024 results on May 13, 2024공시 • Feb 08UBE Corporation Announces Appointment of Hideo Tamada as Director, Effective April 1, 2024UBE Corporation announced Hideo Tamada as Director from Representative Director Senior Managing Executive Officer, Effective from April 1, 2024.Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: JP¥113 (vs JP¥8.39 loss in 3Q 2023)Third quarter 2024 results: EPS: JP¥113 (up from JP¥8.39 loss in 3Q 2023). Revenue: JP¥114.9b (down 7.1% from 3Q 2023). Net income: JP¥10.9b (up JP¥11.7b from 3Q 2023). Profit margin: 9.5% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.Reported Earnings • Nov 07Second quarter 2024 earnings released: EPS: JP¥55.26 (vs JP¥62.67 loss in 2Q 2023)Second quarter 2024 results: EPS: JP¥55.26 (up from JP¥62.67 loss in 2Q 2023). Revenue: JP¥108.9b (down 15% from 2Q 2023). Net income: JP¥5.36b (up JP¥11.4b from 2Q 2023). Profit margin: 4.9% (up from net loss in 2Q 2023). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Upcoming Dividend • Sep 21Upcoming dividend of JP¥50.00 per share at 3.7% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (2.5%).Buying Opportunity • Sep 20Now 21% undervaluedOver the last 90 days, the stock is up 9.7%. The fair value is estimated to be JP¥3,363, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.6% over the last 3 years. Meanwhile, the company became loss making.Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: JP¥37.67 (vs JP¥59.25 in 1Q 2023)First quarter 2024 results: EPS: JP¥37.67 (down from JP¥59.25 in 1Q 2023). Revenue: JP¥109.2b (down 6.0% from 1Q 2023). Net income: JP¥3.66b (down 36% from 1Q 2023). Profit margin: 3.3% (down from 4.9% in 1Q 2023). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Price Target Changed • Jul 01Price target increased by 13% to JP¥2,537Up from JP¥2,245, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥2,471. Stock is up 23% over the past year. The company is forecast to post earnings per share of JP¥260 next year compared to a net loss per share of JP¥72.25 last year.공시 • May 17+ 3 more updatesUBE Corporation Announces Dividend for the Year Ended March 31, 2023UBE Corporation announced dividend for the year ended March 31, 2023 of JPY 45.00 per share compared to JPY 50.00 per share paid a year ago.Reported Earnings • May 16Full year 2023 earnings released: JP¥72.25 loss per share (vs JP¥249 profit in FY 2022)Full year 2023 results: JP¥72.25 loss per share (down from JP¥249 profit in FY 2022). Revenue: JP¥494.7b (down 25% from FY 2022). Net loss: JP¥7.01b (down 129% from profit in FY 2022). Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.Major Estimate Revision • Apr 08Consensus EPS estimates fall by 27%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -JP¥40.20 to -JP¥51.14 per share. Revenue forecast unchanged at JP¥506.1b. Chemicals industry in Japan expected to see average net income growth of 0.7% next year. Consensus price target broadly unchanged at JP¥2,137. Share price was steady at JP¥2,088 over the past week.Upcoming Dividend • Mar 23Upcoming dividend of JP¥45.00 per share at 4.7% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 30 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.7%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).Major Estimate Revision • Mar 15Consensus EPS estimates fall by 15%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -JP¥26.80 to -JP¥30.93 per share. Revenue forecast unchanged at JP¥505.5b. Chemicals industry in Japan expected to see average net income growth of 1.3% next year. Consensus price target of JP¥2,103 unchanged from last update. Share price fell 4.4% to JP¥2,001 over the past week.Major Estimate Revision • Feb 21Consensus EPS estimates fall by 161%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from JP¥516.5b to JP¥508.5b. Losses expected to increase from JP¥10.26 per share to JP¥26.80. Chemicals industry in Japan expected to see average net income growth of 6.6% next year. Consensus price target down from JP¥2,187 to JP¥2,103. Share price rose 3.8% to JP¥2,069 over the past week.Price Target Changed • Feb 20Price target decreased by 7.3% to JP¥2,103Down from JP¥2,270, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥2,069. Stock is down 5.0% over the past year. The company is forecast to post a net loss per share of JP¥26.80 compared to earnings per share of JP¥249 last year.공시 • Feb 11+ 1 more updateUBE Corporation Announces Organizational and Personnel ChangesUBE Corporation has announced that the company's Board of Directors resolved on February 10, 2023, on the following changes to its internal organization, executive officers and their assignments. Newly appointed Executive Officer (as of April 1, 2023): Hirofumi Nonaka, currently Executive Trustee, Deputy, General Manager of Performance, Polymers & Chemicals Div., new position is Executive Officer, Deputy General Manager of Performance Polymers & Chemicals Div. Hirotaka Ishikawa, currently General Manager, Accounting & Finance Dept., new position is Executive Officer, CFO, General Manager of Accounting & Finance Dept. with responsibility for Group Management Dept. and Corporate Planning Dept. Kazunori Yukimoto, currently General Manager of Sakai Factory, Production & Technology Div. and General Manager of Production & Technology Supervisory Dept., Specialty Products Div., new position is Executive Officer, Deputy General Manager of Production & Technology Div. and General Manager of Ube Chemical Factory. Ryo Kawamura, currently General Manager, Legal Dept., new position is Executive Officer, General Manager of Legal Dept., with responsibility for Risk Management Dept., Human Resources Dept. and General Affairs Dept. Shinya Takahashi, currently General Manager, Corporate Planning Dept., new position is Executive Officer, Deputy General Manager of Specialty Products Div. Newly promoted Executive Officers (as of April 1, 2023). Keiichi Nagata, currently Managing Executive Officer, General Manager, Specialty Products Div., new position is Senior Managing Executive Officer, General Manager, Specialty Products Div. Yoichi Funayama, currently Senior Executive Officer, General Manager, Pharmaceutical Div., new position is Managing Executive Officer, General Manager, Pharmaceutical Div. Futoshi Takase, currently Executive Officer, Deputy General Manager of Production & Technology Div. and General Manager of Ube Chemical Factory, new position is Senior Executive Officer, with responsibility for Environment & Safety Dept., Quality Assurance Dept., Purchasing & Logistics Dept. and Ube Corporate Service Dept. Changes to assignments (as of April 1, 2023): Hideo Tamada, currently Senior Managing Executive Officer, CRO, CCO, with responsibility for Risk Management Dept., Human Resources Dept., General Affairs Dept. and Legal Dept., new position is Senior Managing Executive Officer, CRO, CCO, in charge of Risk Management Dept., Human Resources Dept., General Affairs Dept. and Legal Dept. Stepping down as Executive Officer (as of March 31, 2023): Masayuki Fujii, Managing Executive Officer, with responsibility for Group Management Dept., Corporate Planning Dept., Accounting & Finance Dept. and Back Office Optimization Project (Exclusive duty for Director after April 1) Hidetsune Miura, Senior Executive Officer, with responsibility for Environment & Safety Dept., Quality Assurance Dept., Purchasing & Logistics Dept. and Ube Corporate Service Dept. (to be appointed as the President and Representative Director of UBE LOGISTIC SERVICE, LTD. as of April 1) Masarou Suehiro, Executive Officer, with responsibility for Auditing Dept. (to be appointed as a Director, Senior Managing Executive Officer of UBE EXSYMO CO., LTD. as of April 1).Reported Earnings • Feb 04Third quarter 2023 earnings released: JP¥8.39 loss per share (vs JP¥88.13 profit in 3Q 2022)Third quarter 2023 results: JP¥8.39 loss per share (down from JP¥88.13 profit in 3Q 2022). Revenue: JP¥123.6b (down 27% from 3Q 2022). Net loss: JP¥814.0m (down 110% from profit in 3Q 2022). Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 4% per year and the company’s share price has also fallen by 4% per year.공시 • Feb 03+ 2 more updatesUBE Corporation to Report Q4, 2023 Results on May 12, 2023UBE Corporation announced that they will report Q4, 2023 results at 3:00 PM, Tokyo Standard Time on May 12, 2023Price Target Changed • Jan 17Price target decreased to JP¥2,187Down from JP¥2,417, the current price target is an average from 6 analysts. New target price is 13% above last closing price of JP¥1,936. Stock is down 7.2% over the past year. The company is forecast to post earnings per share of JP¥13.50 for next year compared to JP¥249 last year.Board Change • Jan 11Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Outside Director Takefumi Fukumizu was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.Major Estimate Revision • Dec 30Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 EPS estimate fell from JP¥42.53 to JP¥13.50 per share. Revenue forecast steady at JP¥522.5b. Net income forecast to shrink 23% next year vs 0.6% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥2,270 unchanged from last update. Share price was steady at JP¥1,938 over the past week.Buying Opportunity • Dec 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 5.1%. The fair value is estimated to be JP¥2,418, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 2.5% per annum. Earnings is also forecast to grow by 33% per annum over the same time period.Major Estimate Revision • Nov 26Consensus EPS estimates fall by 51%The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from JP¥547.3b to JP¥539.9b. EPS estimate also fell from JP¥95.59 per share to JP¥46.39 per share. Net income forecast to shrink 14% next year vs 1.6% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥2,417 to JP¥2,320. Share price rose 3.0% to JP¥2,039 over the past week.Reported Earnings • Nov 16Second quarter 2023 earnings released: JP¥62.67 loss per share (vs JP¥48.60 profit in 2Q 2022)Second quarter 2023 results: JP¥62.67 loss per share (down from JP¥48.60 profit in 2Q 2022). Revenue: JP¥128.6b (down 20% from 2Q 2022). Net loss: JP¥6.08b (down 227% from profit in 2Q 2022). Revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.Reported Earnings • Nov 06Second quarter 2023 earnings released: JP¥62.67 loss per share (vs JP¥48.60 profit in 2Q 2022)Second quarter 2023 results: JP¥62.67 loss per share (down from JP¥48.60 profit in 2Q 2022). Revenue: JP¥128.6b (down 20% from 2Q 2022). Net loss: JP¥6.08b (down 227% from profit in 2Q 2022). Revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.Upcoming Dividend • Sep 22Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is a comfortable 36% but the company is paying out more than the cash it is generating. Trailing yield: 4.9%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.9%).Major Estimate Revision • Aug 26Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from JP¥495.2b to JP¥513.2b. EPS estimate fell from JP¥202 to JP¥158 per share. Net income forecast to shrink 29% next year vs 3.3% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥2,650 to JP¥2,590. Share price was steady at JP¥2,073 over the past week.Reported Earnings • Aug 05First quarter 2023 earnings released: EPS: JP¥59.25 (vs JP¥47.31 in 1Q 2022)First quarter 2023 results: EPS: JP¥59.25 (up from JP¥47.31 in 1Q 2022). Revenue: JP¥116.2b (down 21% from 1Q 2022). Net income: JP¥5.74b (up 21% from 1Q 2022). Profit margin: 4.9% (up from 3.3% in 1Q 2022). The increase in margin was driven by lower expenses. Over the next year, revenue is expected to shrink by 21% compared to a 9.8% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has remained flat.Reported Earnings • May 16Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: JP¥249 (up from JP¥227 in FY 2021). Revenue: JP¥655.3b (up 6.7% from FY 2021). Net income: JP¥24.5b (up 6.8% from FY 2021). Profit margin: 3.7% (in line with FY 2021). Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) also surpassed analyst estimates by 7.8%. Over the next year, revenue is expected to shrink by 29% compared to a 7.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 3% per year.Major Estimate Revision • May 15Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 EPS estimate fell from JP¥253 to JP¥214. Revenue forecast unchanged from JP¥467.1b at last update. Net income forecast to shrink 26% next year vs 2.3% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥2,592 unchanged from last update. Share price fell 3.8% to JP¥1,993 over the past week.Board Change • May 08Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. 2 highly experienced directors. 4 independent directors (5 non-independent directors). Independent Outside Director Tadahiko Fukuhara was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.공시 • Apr 26UBE Corporation to Report Q3, 2023 Results on Feb 03, 2023UBE Corporation announced that they will report Q3, 2023 results on Feb 03, 2023Reported Earnings • Feb 03Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: JP¥88.13 (up from JP¥86.03 in 3Q 2021). Revenue: JP¥169.9b (up 6.9% from 3Q 2021). Net income: JP¥8.55b (down 1.7% from 3Q 2021). Profit margin: 5.0% (down from 5.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Over the next year, revenue is expected to shrink by 28% compared to a 7.4% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 4% per year.매출 및 비용 세부 내역UBE가 돈을 벌고 사용하는 방법. 최근 발표된 LTM 실적 기준.순이익 및 매출 추이TSE:4208 매출, 비용 및 순이익 (JPY Millions)날짜매출순이익일반관리비연구개발비31 Mar 26462,34323,87284,516031 Dec 25459,33135,38181,800030 Sep 25456,4675,75267,7699,48030 Jun 25471,876-5,25974,907031 Mar 25486,802-4,81663,4089,48031 Dec 24494,911-10,08571,019030 Sep 24493,19720,28056,42410,01730 Jun 24474,40230,13065,699031 Mar 24468,23728,98154,23810,01731 Dec 23459,29114,09554,28110,16530 Sep 23468,0362,35457,65910,16530 Jun 23487,779-9,08956,43210,16531 Mar 23494,738-7,00656,14910,16531 Dec 22547,0365,24660,77211,46230 Sep 22593,36114,61363,53511,46230 Jun 22625,15425,48368,22311,46231 Mar 22655,26524,50072,41911,46231 Dec 21651,56032,06270,93611,03430 Sep 21640,56132,21069,35211,03430 Jun 21624,07129,02268,45211,03431 Mar 21613,88922,93667,62611,03431 Dec 20608,97716,77366,62912,13730 Sep 20612,84312,45868,47212,13730 Jun 20638,94217,10469,98112,13731 Mar 20667,89222,97672,02412,13731 Dec 19687,55624,83073,67811,78330 Sep 19716,95130,93774,08111,78330 Jun 19726,13730,11673,87811,78331 Mar 19730,15732,49973,52211,78331 Dec 18728,98627,85572,98713,01630 Sep 18716,68328,25172,65113,01630 Jun 18705,04132,02872,35013,01631 Mar 18695,57431,68072,20813,01631 Dec 17683,71035,78370,93513,50230 Sep 17662,65132,86069,74313,50230 Jun 17638,08430,58468,45013,50231 Mar 17616,56324,18567,45913,50231 Dec 16599,33314,95565,71413,63930 Sep 16599,55812,50465,38613,63930 Jun 16618,46212,90166,40613,63931 Mar 16641,75019,11166,74313,63931 Dec 15650,30928,74866,51513,76630 Sep 15657,29628,31766,10813,76630 Jun 15654,57022,23265,53913,766양질의 수익: 4208는 고품질 수익을 보유하고 있습니다.이익 마진 증가: 4208는 과거에 흑자전환했습니다.잉여현금흐름 대비 순이익 분석과거 순이익 성장 분석수익추이: 4208의 수익은 지난 5년 동안 연평균 16.1% 감소했습니다.성장 가속화: 4208는 지난해 흑자전환하여 5년 평균과 수익 성장률을 비교하기 어렵습니다.수익 대 산업: 4208는 지난해 흑자전환하여 지난 해 수익 성장률을 Chemicals 업계(10.7%)와 비교하기 어렵습니다.자기자본이익률높은 ROE: 4208의 자본 수익률(5.3%)은 낮음으로 평가됩니다.총자산이익률투하자본수익률우수한 과거 실적 기업을 찾아보세요7D1Y7D1Y7D1YMaterials 산업에서 과거 실적이 우수한 기업.View Financial Health기업 분석 및 재무 데이터 상태데이터최종 업데이트 (UTC 시간)기업 분석2026/05/21 01:06종가2026/05/21 00:00수익2026/03/31연간 수익2026/03/31데이터 소스당사의 기업 분석에 사용되는 데이터는 S&P Global Market Intelligence LLC에서 제공됩니다. 아래 데이터는 이 보고서를 생성하기 위해 분석 모델에서 사용됩니다. 데이터는 정규화되므로 소스가 제공된 후 지연이 발생할 수 있습니다.패키지데이터기간미국 소스 예시 *기업 재무제표10년손익계산서현금흐름표대차대조표SEC 양식 10-KSEC 양식 10-Q분석가 컨센서스 추정치+3년재무 예측분석가 목표주가분석가 리서치 보고서Blue Matrix시장 가격30년주가배당, 분할 및 기타 조치ICE 시장 데이터SEC 양식 S-1지분 구조10년주요 주주내부자 거래SEC 양식 4SEC 양식 13D경영진10년리더십 팀이사회SEC 양식 10-KSEC 양식 DEF 14A주요 개발10년회사 공시SEC 양식 8-K* 미국 증권에 대한 예시이며, 비(非)미국 증권에는 해당 국가의 규제 서식 및 자료원을 사용합니다.별도로 명시되지 않는 한 모든 재무 데이터는 연간 기간을 기준으로 하지만 분기별로 업데이트됩니다. 이를 TTM(최근 12개월) 또는 LTM(지난 12개월) 데이터라고 합니다. 자세히 알아보기.분석 모델 및 스노우플레이크이 보고서를 생성하는 데 사용된 분석 모델에 대한 자세한 내용은 당사의 Github 페이지에서 확인하실 수 있습니다. 또한 보고서 활용 방법에 대한 가이드와 YouTube 튜토리얼도 제공합니다.Simply Wall St 분석 모델을 설계하고 구축한 세계적 수준의 팀에 대해 알아보세요.산업 및 섹터 지표산업 및 섹터 지표는 Simply Wall St가 6시간마다 계산하며, 프로세스에 대한 자세한 내용은 Github에서 확인할 수 있습니다.분석가 소스UBE Corporation는 18명의 분석가가 다루고 있습니다. 이 중 5명의 분석가가 우리 보고서에 입력 데이터로 사용되는 매출 또는 수익 추정치를 제출했습니다. 분석가의 제출 자료는 하루 종일 업데이트됩니다.분석가기관Mikiya YamadaBarclaysTakayuki KuniiBofA Global ResearchAtsushi IkedaCitigroup Inc15명의 분석가 더 보기
공시 • Mar 26+ 3 more updatesUBE Corporation to Report Q1, 2027 Results on Aug 07, 2026UBE Corporation announced that they will report Q1, 2027 results on Aug 07, 2026
Reported Earnings • Aug 06First quarter 2026 earnings released: EPS: JP¥44.90 (vs JP¥49.49 in 1Q 2025)First quarter 2026 results: EPS: JP¥44.90 (down from JP¥49.49 in 1Q 2025). Revenue: JP¥100.5b (down 13% from 1Q 2025). Net income: JP¥4.36b (down 9.2% from 1Q 2025). Profit margin: 4.3% (in line with 1Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Reported Earnings • Jun 25Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: JP¥49.60 loss per share (down from JP¥299 profit in FY 2024). Revenue: JP¥486.8b (up 4.0% from FY 2024). Net loss: JP¥4.82b (down 117% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 68%. Revenue is forecast to stay flat during the next 3 years compared to a 3.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
Reported Earnings • May 13Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: JP¥49.60 loss per share (down from JP¥299 profit in FY 2024). Revenue: JP¥486.8b (up 4.0% from FY 2024). Net loss: JP¥4.82b (down 117% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 68%. Revenue is forecast to stay flat during the next 3 years compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
공시 • Mar 28+ 2 more updatesUBE Corporation to Report Q3, 2026 Results on Feb 04, 2026UBE Corporation announced that they will report Q3, 2026 results on Feb 04, 2026
공시 • Mar 01UBE Corporation to Report Fiscal Year 2025 Results on May 12, 2025UBE Corporation announced that they will report fiscal year 2025 results on May 12, 2025
공시 • May 13UBE Corporation, Annual General Meeting, Jun 25, 2026UBE Corporation, Annual General Meeting, Jun 25, 2026.
공시 • Mar 26+ 3 more updatesUBE Corporation to Report Q1, 2027 Results on Aug 07, 2026UBE Corporation announced that they will report Q1, 2027 results on Aug 07, 2026
공시 • Jan 16UBE Corporation Announces Restructuring of Domestic Production System in Cement-Related BusinessUBE Cement Corporation announced that, at the Board of Directors meeting, MUCC resolved to cease cement production at Kyushu Plant Kanda District 2 by around the end of March 2027 and to transform the district into a recycling promotion base specializing in various types of waste treatment, as described below. The business environment for the cement industry continues to face pressures from declining domestic demand and reduced profitability in export markets. Against this backdrop, MUCC is advancing initiatives to strengthen profitability and improve asset efficiency, aiming to achieve sustainable growth and enhance corporate value over the medium to long term. Meanwhile, as MUCC seeks to achieve carbon neutrality by 2050, a key effort is to improve its thermal energy substitution rate. In particular, MUCC considers it essential to expand the volume of waste treatment for thermal recycling at the Kyushu Plant, which has one of the leading cement production capacities in Japan, and to achieve a thermal energy substitution rate of 50% or more for MUCC as a whole. Under these circumstances, in order to establish an optimal operation system and strengthen the competitiveness of its cement business, MUCC will cease cement production at Kyushu Plant Kanda District 2 by around the end of March 2027 and consolidate operations at Kyushu Plant Kanda District 1, thereby improving the efficiency of production facilities across the entire Kyushu Plant. In addition, to maximize the use of its technologies and further improve the waste treatment substitution rate, MUCC will develop Kyushu Plant Kanda District 2 as a recycling promotion base, utilizing existing facilities for crushing and packing waste plastics and removing chlorine and foreign materials. MUCC will steadily execute these measures to further enhance corporate value and help build a sustainable society.
분석 기사 • Dec 04UBE's (TSE:4208) Dividend Will Be ¥55.00UBE Corporation ( TSE:4208 ) has announced that it will pay a dividend of ¥55.00 per share on the 29th of June. Based...
Declared Dividend • Dec 03First half dividend of JP¥55.00 announcedDividend of JP¥55.00 is the same as last year. Ex-date: 30th March 2026 Payment date: 29th June 2026 Dividend yield will be 4.5%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is not covered by earnings (186% earnings payout ratio) nor is it covered by cash flows (114% cash payout ratio). The dividend has increased by an average of 8.2% per year over the past 10 years. However, payments have been volatile during that time. The company's earnings per share (EPS) would need to grow by 106% to bring the payout ratio under control. EPS is expected to grow by 63% over the next 3 years, which means the dividend may need to be reduced to reach a sustainable payout ratio.
분석 기사 • Sep 05UBE (TSE:4208) Is Reinvesting At Lower Rates Of ReturnDid you know there are some financial metrics that can provide clues of a potential multi-bagger? Ideally, a business...
Reported Earnings • Aug 06First quarter 2026 earnings released: EPS: JP¥44.90 (vs JP¥49.49 in 1Q 2025)First quarter 2026 results: EPS: JP¥44.90 (down from JP¥49.49 in 1Q 2025). Revenue: JP¥100.5b (down 13% from 1Q 2025). Net income: JP¥4.36b (down 9.2% from 1Q 2025). Profit margin: 4.3% (in line with 1Q 2025). Revenue is forecast to stay flat during the next 3 years compared to a 4.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
분석 기사 • Jul 24UBE (TSE:4208) Is Due To Pay A Dividend Of ¥55.00The board of UBE Corporation ( TSE:4208 ) has announced that it will pay a dividend of ¥55.00 per share on the 3rd of...
분석 기사 • Jul 10UBE (TSE:4208) Has Announced A Dividend Of ¥55.00UBE Corporation's ( TSE:4208 ) investors are due to receive a payment of ¥55.00 per share on 3rd of December. This...
Declared Dividend • Jul 09Final dividend of JP¥55.00 announcedDividend of JP¥55.00 is the same as last year. Ex-date: 29th September 2025 Payment date: 3rd December 2025 Dividend yield will be 4.8%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is being paid despite the company being loss-making over the last 12 months and having no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.2% per year over the past 10 years. However, payments have been volatile during that time.
Reported Earnings • Jun 25Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: JP¥49.60 loss per share (down from JP¥299 profit in FY 2024). Revenue: JP¥486.8b (up 4.0% from FY 2024). Net loss: JP¥4.82b (down 117% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 68%. Revenue is forecast to stay flat during the next 3 years compared to a 3.9% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 3% per year, which means it is well ahead of earnings.
New Risk • Jun 24New major risk - Revenue and earnings growthEarnings have declined by 21% per year over the past 5 years. This is considered a major risk. Ultimately, shareholders want to see a good return on their investment and that generally comes from sharing in the company's profits. If profits are declining over an extended period, then in most cases the share price will decline over time unless the company can turn around its fortunes. A trend of falling earnings can be very difficult to turn around. If the company is well already established it may also be a sign the company has matured and is in decline. In addition, if the company pays dividends it will also likely need to reduce or cut them, striking a dual blow to total shareholder returns. Currently, the following risks have been identified for the company: Major Risks Debt is not well covered by operating cash flow (11% operating cash flow to total debt). Dividend is not well covered by earnings and cash flows. Paying a dividend despite being loss-making. Paying a dividend despite having no free cash flows. Earnings have declined by 21% per year over the past 5 years.
Reported Earnings • May 13Full year 2025 earnings: EPS exceeds analyst expectationsFull year 2025 results: JP¥49.60 loss per share (down from JP¥299 profit in FY 2024). Revenue: JP¥486.8b (up 4.0% from FY 2024). Net loss: JP¥4.82b (down 117% from profit in FY 2024). Revenue was in line with analyst estimates. Earnings per share (EPS) surpassed analyst estimates by 68%. Revenue is forecast to stay flat during the next 3 years compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 23% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
공시 • May 12+ 2 more updatesUBE Corporation, Annual General Meeting, Jun 26, 2025UBE Corporation, Annual General Meeting, Jun 26, 2025.
분석 기사 • May 08Here's Why UBE (TSE:4208) Has A Meaningful Debt BurdenDavid Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
Board Change • Apr 28High number of new directorsThere are 6 new directors who have joined the board in the last 3 years. Independent Outside Director Tatsuya Tanaka was the last director to join the board, commencing their role in 2023. The company’s lack of board continuity is considered a risk according to the Simply Wall St Risk Model.
공시 • Apr 02UBE Corporation (TSE:4208) completed the acquisition of Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for approximately €500 million.UBE Corporation (TSE:4208) signed a contract to acquire Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for an enterprise value of €460 million on October 3, 2024. For the last twelve months period ending September 30, 2024, Urethane Systems Business of LANXESS reported total revenue of €265 million and EBITDA of €50 million. The acquisition price is expected to be confirmed based on the price adjustment indicated in the stock purchase agreement. The acquisition will be financed through cash on hand and interest-bearing debt. The Urethane Systems business comprises 5 manufacturing sites globally as well as application laboratories in the USA, Europe and China. UBE Corporation will take over all operations from LANXESS with a total of around 400 employees. LANXESS will use the proceeds to reduce its net debt. The transaction is subject to the approval of the relevant authorities including regulatory approval. The transaction is expected to close in the first half of 2025. Nomura Holding America, Inc. acted as financial advisor to UBE Corporation. Matthias Töke, Katharina Spenner LL.M., Joachim Fröhlich LL.M., Katharina Weiner, Daniel Bork, Christoph Becker, Ariane Schaaf, Simone (Bach) Rieken LL.M., Johannes M. Baumann, LL.M., Christian Atzler, Christian Vocke, Richard Raoul Stefanink, Patrick H. Wilkening, Markus Hecht, Christian Reichel and Nicolas Kredel LL.M. of Baker & Mckenzie Partnerschaft Von Rechtsanwälten Wirtschaftsprüfern,Steuerberatern Und Solicitors acted as legal advisor to UBE Corporation. Masahiro Inaba, Byron Frost and Tetsuo Tsujimoto of Baker & McKenzie (Gaikokuho Joint Enterprise) acted as legal advisor to UBE Corporation. UBE Corporation (TSE:4208) completed the acquisition of Urethane Systems Business of LANXESS Aktiengesellschaft (XTRA:LXS) for approximately €500 million on April 1, 2025. All relevant antitrust authorities had granted the necessary approvals for the transaction
공시 • Mar 28+ 2 more updatesUBE Corporation to Report Q3, 2026 Results on Feb 04, 2026UBE Corporation announced that they will report Q3, 2026 results on Feb 04, 2026
공시 • Mar 01UBE Corporation to Report Fiscal Year 2025 Results on May 12, 2025UBE Corporation announced that they will report fiscal year 2025 results on May 12, 2025
공시 • Feb 19+ 1 more updateUbe Corporation Announces CEO Changes, Effective from April 1, 2025UBE Corporation announced that its Board of Directors resolved on February 19, 2025, to make the following changes to directors. Masato Izumihara, Current Position: President and Representative Director CEO, New Position: Chairman of the Board of Directors. Yuki Nishida, Current Position: Representative Director Senior Managing Executive Officer, New Position: President and Representative Director CEO. Yuki Nishida: Date of Birth: January 16, 1962. Birthplace: Hiroshima Prefecture. Career Highlights: March 1987 Master's Degree of Applied Chemistry, Faculty of Engineering, Hiroshima University; April 1987 Joined Ube Industries Ltd. (currently UBE Corporation); June 1987 Fine Chemicals Manufacturing Department, Ube Chemical Factory; November 1990 Development Department, Chemicals Division; March 1996 Business Development Department, Fine & Industrial Chemicals Business Unit, Chemicals & Plastics Division; February 2000 Transferred to UBE Europe (Dusseldorf, Germany); April 2003 Transferred to UBE Chemicals Europe (Madrid, Spain); January 2005 Sales Group Leader, Fine Chemicals Business Unit, Specialty Chemicals & Products Division; December 2006; General Manager, Fine Chemicals Business Unit, Specialty Chemicals & Products Division; April 2015; General Manager, Battery Materials and Fine Chemicals Business Unit, Chemicals Company; April 2016: Executive Officer General Manager, Battery Materials and Fine Chemicals Business Unit, Chemicals Company; April 2017: Executive Officer General Manager, Battery Materials and Fine Chemicals Division, Chemicals Company; April 2019: Managing Executive Officer General Manager, Engineering Plastics & Fine Chemicals Division, Chemicals Company; April 2021: Managing Executive Officer General Manager, Engineering Plastics & Fine Chemicals Division; April 2022: Senior Managing Executive Officer Assistant to the President, General Manager, Production & Technology Division, and DX Promotion Office, with responsibility for Information Systems Department; July 2022: Senior Managing Executive Officer Assistant to the President, General Manager, Production & Technology Division, and DX Promotion Office, with responsibility for Information Systems Department and C1 Chemicals Project; April 2024: Senior Managing Executive Officer Assistant to the President, General Manager, DX Promotion Office, with responsibility for Information Systems Department and C1 Chemicals Project; June 2024: Representative Director and Senior Managing Executive Officer Assistant to the President, General Manager, DX Promotion Office, with responsibility for Information Systems Department and C1 Chemicals Project (current position); April 2025: President and Representative Director CEO, with responsibility for DX Promotion Office, Information Systems Department, and C1 Chemicals Project (pending approval).
공시 • Jan 28+ 1 more updateUBE Corporation Revises Consolidated Earnings Guidance for the Fiscal Year Ending March 31, 2025UBE Corporation revised consolidated earnings guidance for the fiscal year ending March 31, 2025. For the year, the company expects net sales to be JPY 490.0 billion against previous guidance of JPY 510.0 billion. Operating profit to be JPY 16.0 billion against previous guidance of JPY 27.0 billion. Loss attributable to owners of parent to be JPY 17.5 billion against previous guidance of profit attributable to owners of parent of JPY 29.5 billion. Net loss per share to be JPY 180.24 against previous guidance of net income per share to be JPY 303.89. Reasons for the Revision: Net sales are expected to fall below the previous forecast mainly due to the transfer of management rights of UBE Steel Co. Ltd. in Machinery Segment, in November 2024. Operating profit is also projected to come in lower than the previous forecast as sales of caprolactam and nylon polymer in the Polymers & Chemicals Segment have been sluggish due to the impact of oversupply by Chinese companies. Ordinary profit is projected to be lower than the previous forecast due to a decrease in operating profit as mentioned above. Additionally, in the first half (interim period), the company dissolved an equity-method affiliate engaged in the elastomer business in Malaysia, recording share of loss of entities accounted for using the equity method. Profit attributable to owners of parent is expected to be lower than the previous forecast. Ordinary profit is expected to decline as described earlier. Additionally, as a result of the decision to implement structural reform in the basic businesses, the company plans to record approximately JPY 35 billion in impairment losses and other related expenses. For details on the structural reform of the basic businesses, please refer to UBE Announces Structural Reform of Basic Businesses to Achieve Vision for 2030 released on January 28, 2025.
Declared Dividend • Dec 04First half dividend of JP¥55.00 announcedShareholders will receive a dividend of JP¥55.00. Ex-date: 28th March 2025 Payment date: 27th June 2025 Dividend yield will be 4.6%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is covered by earnings (53% earnings payout ratio) but the company has no free cash flows available, indicating it may be using cash reserves or debt to pay the dividend. The dividend has increased by an average of 8.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 45% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
New Risk • Nov 09New major risk - Financial positionThe company's debt is not well covered by operating cash flow. Operating cash flow to total debt ratio: 15% This is considered a major risk. If the company's operating cash flows are too small relative to the size of their debt, it increases their balance sheet risk. The company has less cash from operations to cover its expenses from servicing large debt and it increases the risk of liquidity issues. It also extends the time it would take for the company to pay back the debt in full, meaning it may not be able to easily pay it all off in a distress scenario. Currently, the following risks have been identified for the company: Major Risk Debt is not well covered by operating cash flow (15% operating cash flow to total debt). Minor Risk Paying a dividend despite having no free cash flows.
Reported Earnings • Nov 09Second quarter 2025 earnings released: JP¥46.20 loss per share (vs JP¥55.26 profit in 2Q 2024)Second quarter 2025 results: JP¥46.20 loss per share (down from JP¥55.26 profit in 2Q 2024). Revenue: JP¥127.7b (up 17% from 2Q 2024). Net loss: JP¥4.49b (down 184% from profit in 2Q 2024). Revenue is forecast to grow 5.0% p.a. on average during the next 3 years, compared to a 5.1% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 15% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
분석 기사 • Nov 08Getting In Cheap On UBE Corporation (TSE:4208) Might Be DifficultThere wouldn't be many who think UBE Corporation's ( TSE:4208 ) price-to-sales (or "P/S") ratio of 0.5x is worth a...
공시 • Oct 31UBE Corporation Revises Earnings Forecast for the First Half of Fiscal Year Ending March 31, 2025UBE Corporation revised earnings forecast for the First Half of fiscal year ending March 31, 2025. For the period,the company expected net sales of JPY 243,000 Million operating profit of JPY 6,000 Million and profit attributable to owners of parent of JPY 300 million or JPY 3.09 per basic share as compared to previous guidance of net sales of JPY 238,000 Million operating profit of JPY 7,500 Million and profit attributable to owners of parent of JPY 8,000 million or JPY 82.41 per basic share. Reasons for the Revision: Net sales are expected to exceed the previous forecast due to an increase in the selling price of elastomers as a result of rising raw material prices, despite sluggish sales of certain products in the Specialty Products Segment. Operating profit is projected to be lower than the previous forecast due to the impact of the lower of cost or market method on caprolactam, nylon polymers, and other products, in the Polymers & Chemicals Segment. Ordinary profit and profit attributable to owners of parent are expected to be significantly lower than previously forecast due to the posting of a share of loss of entities accounted for using equity method following the dissolution of LOTTE UBE SYNTHETIC RUBBER SDN. BHD., an equity method affiliate.
분석 기사 • Oct 17Investors Could Be Concerned With UBE's (TSE:4208) Returns On CapitalWhen researching a stock for investment, what can tell us that the company is in decline? A business that's potentially...
공시 • Oct 04+ 1 more updateiSigma Capital Corporation agreed to acquire 84.25% stake in Ube Steel Co.,Ltd from UBE Corporation (TSE:4208).iSigma Capital Corporation agreed to acquire 84.25% stake in Ube Steel Co.,Ltd from UBE Corporation (TSE:4208) on October 3, 2024.
Upcoming Dividend • Sep 20Upcoming dividend of JP¥55.00 per shareEligible shareholders must have bought the stock before 27 September 2024. Payment date: 04 December 2024. Payout ratio is a comfortable 34% but the company is paying out more than the cash it is generating. Trailing yield: 4.1%. Within top quartile of Japanese dividend payers (3.8%). Higher than average of industry peers (2.4%).
Reported Earnings • Aug 06First quarter 2025 earnings released: EPS: JP¥49.49 (vs JP¥37.67 in 1Q 2024)First quarter 2025 results: EPS: JP¥49.49 (up from JP¥37.67 in 1Q 2024). Revenue: JP¥115.4b (up 5.6% from 1Q 2024). Net income: JP¥4.80b (up 31% from 1Q 2024). Profit margin: 4.2% (up from 3.3% in 1Q 2024). The increase in margin was driven by higher revenue. Revenue is forecast to grow 5.1% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 25% per year but the company’s share price has increased by 4% per year, which means it is well ahead of earnings.
Valuation Update With 7 Day Price Move • Aug 05Investor sentiment deteriorates as stock falls 19%After last week's 19% share price decline to JP¥2,185, the stock trades at a forward P/E ratio of 7x. Average forward P/E is 12x in the Chemicals industry in Japan. Total returns to shareholders of 12% over the past three years. Simply Wall St's valuation model estimates the intrinsic value at JP¥1,711 per share.
Declared Dividend • Jul 11Final dividend of JP¥55.00 announcedShareholders will receive a dividend of JP¥55.00. Ex-date: 27th September 2024 Payment date: 4th December 2024 Dividend yield will be 3.9%, which is higher than the industry average of 2.2%. Sustainability & Growth Dividend is well covered by both earnings (35% earnings payout ratio) and cash flows (49% cash payout ratio). The dividend has increased by an average of 8.2% per year over the past 10 years. However, payments have been volatile during that time. EPS is expected to grow by 28% over the next 3 years, which should provide support to the dividend and adequate earnings cover.
Reported Earnings • Jun 26Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2024 results: EPS: JP¥299 (up from JP¥72.25 loss in FY 2023). Revenue: JP¥468.2b (down 5.4% from FY 2023). Net income: JP¥29.0b (up JP¥36.0b from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) exceeded analyst estimates by 31%. Revenue is forecast to grow 5.4% p.a. on average during the next 3 years, compared to a 5.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 8% per year, which means it is well ahead of earnings.
Price Target Changed • Jun 15Price target increased by 9.8% to JP¥3,092Up from JP¥2,817, the current price target is an average from 6 analysts. New target price is 13% above last closing price of JP¥2,735. Stock is up 11% over the past year. The company is forecast to post earnings per share of JP¥301 for next year compared to JP¥299 last year.
Major Estimate Revision • Jun 15Consensus EPS estimates increase by 14%The consensus outlook for earnings per share (EPS) in fiscal year 2025 has improved. 2025 revenue forecast increased from JP¥499.9b to JP¥515.7b. EPS estimate increased from JP¥265 to JP¥301 per share. Net income forecast to grow 0.8% next year vs 10% growth forecast for Chemicals industry in Japan. Consensus price target up from JP¥2,817 to JP¥3,092. Share price was steady at JP¥2,735 over the past week.
Reported Earnings • May 16Full year 2024 earnings: EPS exceeds analyst expectations while revenues lag behindFull year 2024 results: EPS: JP¥299 (up from JP¥72.25 loss in FY 2023). Revenue: JP¥468.2b (down 5.4% from FY 2023). Net income: JP¥29.0b (up JP¥36.0b from FY 2023). Profit margin: 6.2% (up from net loss in FY 2023). The move to profitability was driven by lower expenses. Revenue missed analyst estimates by 1.1%. Earnings per share (EPS) exceeded analyst estimates by 31%. Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 41% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
공시 • May 15+ 2 more updatesUBE Corporation to Report First Half, 2025 Results on Nov 07, 2024UBE Corporation announced that they will report first half, 2025 results on Nov 07, 2024
Buy Or Sell Opportunity • May 14Now 21% overvalued after recent price riseOver the last 90 days, the stock has risen 20% to JP¥3,014. The fair value is estimated to be JP¥2,489, however this is not to be taken as a sell recommendation but rather should be used as a guide only. Revenue has declined by 11% over the last 3 years. Earnings per share has declined by 54%. For the next 3 years, revenue is forecast to grow by 5.0% per annum. Earnings are also forecast to grow by 19% per annum over the same time period.
분석 기사 • May 01Is UBE (TSE:4208) A Risky Investment?Warren Buffett famously said, 'Volatility is far from synonymous with risk.' So it might be obvious that you need to...
공시 • Apr 26+ 1 more updateUBE Corporation, Annual General Meeting, Jun 26, 2024UBE Corporation, Annual General Meeting, Jun 26, 2024. Agenda: To approve the Change of Representative Director and Executive Personnel.
분석 기사 • Apr 13Estimating The Fair Value Of UBE Corporation (TSE:4208)Key Insights UBE's estimated fair value is JP¥2,482 based on 2 Stage Free Cash Flow to Equity With JP¥2,830 share...
Price Target Changed • Mar 27Price target increased by 8.3% to JP¥2,817Up from JP¥2,600, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥2,750. Stock is up 33% over the past year. The company is forecast to post earnings per share of JP¥230 next year compared to a net loss per share of JP¥72.25 last year.
Upcoming Dividend • Mar 21Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 28 March 2024. Payment date: 01 July 2024. Payout ratio is a comfortable 65% and this is well supported by cash flows. Trailing yield: 3.6%. Within top quartile of Japanese dividend payers (3.2%). Higher than average of industry peers (2.1%).
분석 기사 • Mar 19Market Participants Recognise UBE Corporation's (TSE:4208) EarningsWith a price-to-earnings (or "P/E") ratio of 18.2x UBE Corporation ( TSE:4208 ) may be sending bearish signals at the...
공시 • Mar 02UBE Corporation to Report Fiscal Year 2024 Results on May 13, 2024UBE Corporation announced that they will report fiscal year 2024 results on May 13, 2024
공시 • Feb 08UBE Corporation Announces Appointment of Hideo Tamada as Director, Effective April 1, 2024UBE Corporation announced Hideo Tamada as Director from Representative Director Senior Managing Executive Officer, Effective from April 1, 2024.
Reported Earnings • Feb 07Third quarter 2024 earnings released: EPS: JP¥113 (vs JP¥8.39 loss in 3Q 2023)Third quarter 2024 results: EPS: JP¥113 (up from JP¥8.39 loss in 3Q 2023). Revenue: JP¥114.9b (down 7.1% from 3Q 2023). Net income: JP¥10.9b (up JP¥11.7b from 3Q 2023). Profit margin: 9.5% (up from net loss in 3Q 2023). The move to profitability was driven by lower expenses. Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 5.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 54% per year but the company’s share price has increased by 7% per year, which means it is well ahead of earnings.
Reported Earnings • Nov 07Second quarter 2024 earnings released: EPS: JP¥55.26 (vs JP¥62.67 loss in 2Q 2023)Second quarter 2024 results: EPS: JP¥55.26 (up from JP¥62.67 loss in 2Q 2023). Revenue: JP¥108.9b (down 15% from 2Q 2023). Net income: JP¥5.36b (up JP¥11.4b from 2Q 2023). Profit margin: 4.9% (up from net loss in 2Q 2023). Revenue is forecast to grow 4.9% p.a. on average during the next 3 years, compared to a 4.8% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 51% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Upcoming Dividend • Sep 21Upcoming dividend of JP¥50.00 per share at 3.7% yieldEligible shareholders must have bought the stock before 28 September 2023. Payment date: 04 December 2023. The company is not currently making a profit and is not cash flow positive. Trailing yield: 3.7%. Within top quartile of Japanese dividend payers (3.3%). Higher than average of industry peers (2.5%).
Buying Opportunity • Sep 20Now 21% undervaluedOver the last 90 days, the stock is up 9.7%. The fair value is estimated to be JP¥3,363, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 6.6% over the last 3 years. Meanwhile, the company became loss making.
Reported Earnings • Aug 08First quarter 2024 earnings released: EPS: JP¥37.67 (vs JP¥59.25 in 1Q 2023)First quarter 2024 results: EPS: JP¥37.67 (down from JP¥59.25 in 1Q 2023). Revenue: JP¥109.2b (down 6.0% from 1Q 2023). Net income: JP¥3.66b (down 36% from 1Q 2023). Profit margin: 3.3% (down from 4.9% in 1Q 2023). Revenue is forecast to grow 4.8% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 38% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Price Target Changed • Jul 01Price target increased by 13% to JP¥2,537Up from JP¥2,245, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥2,471. Stock is up 23% over the past year. The company is forecast to post earnings per share of JP¥260 next year compared to a net loss per share of JP¥72.25 last year.
공시 • May 17+ 3 more updatesUBE Corporation Announces Dividend for the Year Ended March 31, 2023UBE Corporation announced dividend for the year ended March 31, 2023 of JPY 45.00 per share compared to JPY 50.00 per share paid a year ago.
Reported Earnings • May 16Full year 2023 earnings released: JP¥72.25 loss per share (vs JP¥249 profit in FY 2022)Full year 2023 results: JP¥72.25 loss per share (down from JP¥249 profit in FY 2022). Revenue: JP¥494.7b (down 25% from FY 2022). Net loss: JP¥7.01b (down 129% from profit in FY 2022). Revenue is forecast to grow 4.0% p.a. on average during the next 3 years, compared to a 3.7% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 21% per year but the company’s share price has increased by 9% per year, which means it is well ahead of earnings.
Major Estimate Revision • Apr 08Consensus EPS estimates fall by 27%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -JP¥40.20 to -JP¥51.14 per share. Revenue forecast unchanged at JP¥506.1b. Chemicals industry in Japan expected to see average net income growth of 0.7% next year. Consensus price target broadly unchanged at JP¥2,137. Share price was steady at JP¥2,088 over the past week.
Upcoming Dividend • Mar 23Upcoming dividend of JP¥45.00 per share at 4.7% yieldEligible shareholders must have bought the stock before 30 March 2023. Payment date: 30 June 2023. The company is paying out more than 100% of its profits and is cash flow negative. Trailing yield: 4.7%. Within top quartile of Japanese dividend payers (3.6%). Higher than average of industry peers (2.8%).
Major Estimate Revision • Mar 15Consensus EPS estimates fall by 15%The consensus outlook for fiscal year 2023 has been updated. 2023 expected loss increased from -JP¥26.80 to -JP¥30.93 per share. Revenue forecast unchanged at JP¥505.5b. Chemicals industry in Japan expected to see average net income growth of 1.3% next year. Consensus price target of JP¥2,103 unchanged from last update. Share price fell 4.4% to JP¥2,001 over the past week.
Major Estimate Revision • Feb 21Consensus EPS estimates fall by 161%The consensus outlook for earnings per share (EPS) in fiscal year 2023 has deteriorated. 2023 revenue forecast decreased from JP¥516.5b to JP¥508.5b. Losses expected to increase from JP¥10.26 per share to JP¥26.80. Chemicals industry in Japan expected to see average net income growth of 6.6% next year. Consensus price target down from JP¥2,187 to JP¥2,103. Share price rose 3.8% to JP¥2,069 over the past week.
Price Target Changed • Feb 20Price target decreased by 7.3% to JP¥2,103Down from JP¥2,270, the current price target is an average from 6 analysts. New target price is approximately in line with last closing price of JP¥2,069. Stock is down 5.0% over the past year. The company is forecast to post a net loss per share of JP¥26.80 compared to earnings per share of JP¥249 last year.
공시 • Feb 11+ 1 more updateUBE Corporation Announces Organizational and Personnel ChangesUBE Corporation has announced that the company's Board of Directors resolved on February 10, 2023, on the following changes to its internal organization, executive officers and their assignments. Newly appointed Executive Officer (as of April 1, 2023): Hirofumi Nonaka, currently Executive Trustee, Deputy, General Manager of Performance, Polymers & Chemicals Div., new position is Executive Officer, Deputy General Manager of Performance Polymers & Chemicals Div. Hirotaka Ishikawa, currently General Manager, Accounting & Finance Dept., new position is Executive Officer, CFO, General Manager of Accounting & Finance Dept. with responsibility for Group Management Dept. and Corporate Planning Dept. Kazunori Yukimoto, currently General Manager of Sakai Factory, Production & Technology Div. and General Manager of Production & Technology Supervisory Dept., Specialty Products Div., new position is Executive Officer, Deputy General Manager of Production & Technology Div. and General Manager of Ube Chemical Factory. Ryo Kawamura, currently General Manager, Legal Dept., new position is Executive Officer, General Manager of Legal Dept., with responsibility for Risk Management Dept., Human Resources Dept. and General Affairs Dept. Shinya Takahashi, currently General Manager, Corporate Planning Dept., new position is Executive Officer, Deputy General Manager of Specialty Products Div. Newly promoted Executive Officers (as of April 1, 2023). Keiichi Nagata, currently Managing Executive Officer, General Manager, Specialty Products Div., new position is Senior Managing Executive Officer, General Manager, Specialty Products Div. Yoichi Funayama, currently Senior Executive Officer, General Manager, Pharmaceutical Div., new position is Managing Executive Officer, General Manager, Pharmaceutical Div. Futoshi Takase, currently Executive Officer, Deputy General Manager of Production & Technology Div. and General Manager of Ube Chemical Factory, new position is Senior Executive Officer, with responsibility for Environment & Safety Dept., Quality Assurance Dept., Purchasing & Logistics Dept. and Ube Corporate Service Dept. Changes to assignments (as of April 1, 2023): Hideo Tamada, currently Senior Managing Executive Officer, CRO, CCO, with responsibility for Risk Management Dept., Human Resources Dept., General Affairs Dept. and Legal Dept., new position is Senior Managing Executive Officer, CRO, CCO, in charge of Risk Management Dept., Human Resources Dept., General Affairs Dept. and Legal Dept. Stepping down as Executive Officer (as of March 31, 2023): Masayuki Fujii, Managing Executive Officer, with responsibility for Group Management Dept., Corporate Planning Dept., Accounting & Finance Dept. and Back Office Optimization Project (Exclusive duty for Director after April 1) Hidetsune Miura, Senior Executive Officer, with responsibility for Environment & Safety Dept., Quality Assurance Dept., Purchasing & Logistics Dept. and Ube Corporate Service Dept. (to be appointed as the President and Representative Director of UBE LOGISTIC SERVICE, LTD. as of April 1) Masarou Suehiro, Executive Officer, with responsibility for Auditing Dept. (to be appointed as a Director, Senior Managing Executive Officer of UBE EXSYMO CO., LTD. as of April 1).
Reported Earnings • Feb 04Third quarter 2023 earnings released: JP¥8.39 loss per share (vs JP¥88.13 profit in 3Q 2022)Third quarter 2023 results: JP¥8.39 loss per share (down from JP¥88.13 profit in 3Q 2022). Revenue: JP¥123.6b (down 27% from 3Q 2022). Net loss: JP¥814.0m (down 110% from profit in 3Q 2022). Revenue is forecast to grow 3.9% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has fallen by 4% per year and the company’s share price has also fallen by 4% per year.
공시 • Feb 03+ 2 more updatesUBE Corporation to Report Q4, 2023 Results on May 12, 2023UBE Corporation announced that they will report Q4, 2023 results at 3:00 PM, Tokyo Standard Time on May 12, 2023
Price Target Changed • Jan 17Price target decreased to JP¥2,187Down from JP¥2,417, the current price target is an average from 6 analysts. New target price is 13% above last closing price of JP¥1,936. Stock is down 7.2% over the past year. The company is forecast to post earnings per share of JP¥13.50 for next year compared to JP¥249 last year.
Board Change • Jan 11Less than half of directors are independentFollowing the recent departure of a director, there are only 4 independent directors on the board. The company's board is composed of: 4 independent directors. 5 non-independent directors. Independent Outside Director Takefumi Fukumizu was the last independent director to join the board, commencing their role in 2022. The company's minority of independent directors is a risk according to the Simply Wall St Risk Model.
Major Estimate Revision • Dec 30Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 EPS estimate fell from JP¥42.53 to JP¥13.50 per share. Revenue forecast steady at JP¥522.5b. Net income forecast to shrink 23% next year vs 0.6% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥2,270 unchanged from last update. Share price was steady at JP¥1,938 over the past week.
Buying Opportunity • Dec 21Now 20% undervalued after recent price dropOver the last 90 days, the stock is down 5.1%. The fair value is estimated to be JP¥2,418, however this is not to be taken as a buy recommendation but rather should be used as a guide only. Revenue has declined by 3.4% over the last 3 years, while earnings per share has been flat. For the next 3 years, revenue is forecast to grow by 2.5% per annum. Earnings is also forecast to grow by 33% per annum over the same time period.
Major Estimate Revision • Nov 26Consensus EPS estimates fall by 51%The consensus outlook for earnings per share (EPS) in 2023 has deteriorated. 2023 revenue forecast decreased from JP¥547.3b to JP¥539.9b. EPS estimate also fell from JP¥95.59 per share to JP¥46.39 per share. Net income forecast to shrink 14% next year vs 1.6% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥2,417 to JP¥2,320. Share price rose 3.0% to JP¥2,039 over the past week.
Reported Earnings • Nov 16Second quarter 2023 earnings released: JP¥62.67 loss per share (vs JP¥48.60 profit in 2Q 2022)Second quarter 2023 results: JP¥62.67 loss per share (down from JP¥48.60 profit in 2Q 2022). Revenue: JP¥128.6b (down 20% from 2Q 2022). Net loss: JP¥6.08b (down 227% from profit in 2Q 2022). Revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 4.2% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 5% per year, which means it is significantly lagging earnings.
Reported Earnings • Nov 06Second quarter 2023 earnings released: JP¥62.67 loss per share (vs JP¥48.60 profit in 2Q 2022)Second quarter 2023 results: JP¥62.67 loss per share (down from JP¥48.60 profit in 2Q 2022). Revenue: JP¥128.6b (down 20% from 2Q 2022). Net loss: JP¥6.08b (down 227% from profit in 2Q 2022). Revenue is forecast to grow 1.5% p.a. on average during the next 3 years, compared to a 4.5% growth forecast for the Chemicals industry in Japan. Over the last 3 years on average, earnings per share has increased by 2% per year but the company’s share price has fallen by 7% per year, which means it is significantly lagging earnings.
Upcoming Dividend • Sep 22Upcoming dividend of JP¥50.00 per shareEligible shareholders must have bought the stock before 29 September 2022. Payment date: 02 December 2022. Payout ratio is a comfortable 36% but the company is paying out more than the cash it is generating. Trailing yield: 4.9%. Within top quartile of Japanese dividend payers (3.7%). Higher than average of industry peers (2.9%).
Major Estimate Revision • Aug 26Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 revenue forecast increased from JP¥495.2b to JP¥513.2b. EPS estimate fell from JP¥202 to JP¥158 per share. Net income forecast to shrink 29% next year vs 3.3% growth forecast for Chemicals industry in Japan . Consensus price target down from JP¥2,650 to JP¥2,590. Share price was steady at JP¥2,073 over the past week.
Reported Earnings • Aug 05First quarter 2023 earnings released: EPS: JP¥59.25 (vs JP¥47.31 in 1Q 2022)First quarter 2023 results: EPS: JP¥59.25 (up from JP¥47.31 in 1Q 2022). Revenue: JP¥116.2b (down 21% from 1Q 2022). Net income: JP¥5.74b (up 21% from 1Q 2022). Profit margin: 4.9% (up from 3.3% in 1Q 2022). The increase in margin was driven by lower expenses. Over the next year, revenue is expected to shrink by 21% compared to a 9.8% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has increased by 4% per year whereas the company’s share price has remained flat.
Reported Earnings • May 16Full year 2022 earnings: EPS and revenues exceed analyst expectationsFull year 2022 results: EPS: JP¥249 (up from JP¥227 in FY 2021). Revenue: JP¥655.3b (up 6.7% from FY 2021). Net income: JP¥24.5b (up 6.8% from FY 2021). Profit margin: 3.7% (in line with FY 2021). Revenue exceeded analyst estimates by 1.2%. Earnings per share (EPS) also surpassed analyst estimates by 7.8%. Over the next year, revenue is expected to shrink by 29% compared to a 7.9% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has remained flat whereas the company’s share price has fallen by 3% per year.
Major Estimate Revision • May 15Consensus forecasts updatedThe consensus outlook for 2023 has been updated. 2023 EPS estimate fell from JP¥253 to JP¥214. Revenue forecast unchanged from JP¥467.1b at last update. Net income forecast to shrink 26% next year vs 2.3% growth forecast for Chemicals industry in Japan . Consensus price target of JP¥2,592 unchanged from last update. Share price fell 3.8% to JP¥1,993 over the past week.
Board Change • May 08Less than half of directors are independentThere is 1 new director who has joined the board in the last 3 years. The new board member was an independent director. The company's board is composed of: 1 new director. 7 experienced directors. 2 highly experienced directors. 4 independent directors (5 non-independent directors). Independent Outside Director Tadahiko Fukuhara was the last independent director to join the board, commencing their role in 2022. The following issues are considered to be risks according to the Simply Wall St Risk Model: Minority of independent directors. Insufficient board refreshment.
공시 • Apr 26UBE Corporation to Report Q3, 2023 Results on Feb 03, 2023UBE Corporation announced that they will report Q3, 2023 results on Feb 03, 2023
Reported Earnings • Feb 03Third quarter 2022 earnings: EPS and revenues exceed analyst expectationsThird quarter 2022 results: EPS: JP¥88.13 (up from JP¥86.03 in 3Q 2021). Revenue: JP¥169.9b (up 6.9% from 3Q 2021). Net income: JP¥8.55b (down 1.7% from 3Q 2021). Profit margin: 5.0% (down from 5.5% in 3Q 2021). The decrease in margin was driven by higher expenses. Revenue exceeded analyst estimates by 4.9%. Earnings per share (EPS) also surpassed analyst estimates by 27%. Over the next year, revenue is expected to shrink by 28% compared to a 7.4% growth forecast for the industry in Japan. Over the last 3 years on average, earnings per share has fallen by 1% per year whereas the company’s share price has fallen by 4% per year.